Copyright
©The Author(s) 2021.
World J Diabetes. May 15, 2021; 12(5): 658-672
Published online May 15, 2021. doi: 10.4239/wjd.v12.i5.658
Published online May 15, 2021. doi: 10.4239/wjd.v12.i5.658
Figure 2 Representative fluorescent micrograph of a paraffin section of myenteric ganglia from the ileum of a control rat after matrix metalloproteinase 9-tissue inhibitor of metalloproteinase 1 double-labelling immunohistochemistry.
A: Matrix metalloproteinase 9 immunoreactivity is indicated in red; B: tissue inhibitor of metalloproteinase 1 immunoreactivity is shown in green; and C: The merge is depicted on. Scale bar: 20 μm. MG: Myenteric ganglia; LSM: Longitudinal smooth muscle layer; CSM: Circular smooth muscle layer; arrows-blood vessels.
- Citation: Bódi N, Mezei D, Chakraborty P, Szalai Z, Barta BP, Balázs J, Rázga Z, Hermesz E, Bagyánszki M. Diabetes-related intestinal region-specific thickening of ganglionic basement membrane and regionally decreased matrix metalloproteinase 9 expression in myenteric ganglia. World J Diabetes 2021; 12(5): 658-672
- URL: https://www.wjgnet.com/1948-9358/full/v12/i5/658.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i5.658